Dearfield K L, Harrington-Brock K, Doerr C L, Parker L, Moore M M
Health Effects Division, U.S. Environmental Protection Agency, Washington, DC 20460.
Mutat Res. 1993 Jan;301(1):57-63. doi: 10.1016/0165-7992(93)90057-3.
The L5178Y mouse lymphoma assay was used to examine the potential mutagenicity of three halogenated pyridine compounds. Position effects of the halogen moiety and the role of metabolic activation were analyzed based on induced mutant frequency, gross chromosome aberrations, and micronuclei. Without activation, 2-chloropyridine, 3-chloropyridine, and 2-chloro-5-trifluoromethylpyridine produced a small increase in mutant frequency; only the 2-chloropyridine activity was significantly increased with activation. All three compounds were also clastogenic as demonstrated by increases in chromosome aberrations and micronuclei (except for 2-chloro-5-trifluoromethylpyridine which did not induce micronuclei either with or without activation).
采用L5178Y小鼠淋巴瘤试验检测三种卤代吡啶化合物的潜在致突变性。基于诱导突变频率、染色体总畸变率和微核率,分析了卤素部分的位置效应和代谢活化的作用。未经活化时,2-氯吡啶、3-氯吡啶和2-氯-5-三氟甲基吡啶使突变频率略有增加;仅2-氯吡啶经活化后活性显著增加。所有三种化合物均具有染色体断裂效应,表现为染色体畸变率和微核率增加(2-氯-5-三氟甲基吡啶无论有无活化均未诱导微核形成除外)。